{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T10:25:51Z","timestamp":1777026351869,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1136\/ijgc-2019-000386","type":"journal-article","created":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T16:55:12Z","timestamp":1599929712000},"page":"518-523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Stage IVA cervical cancer: outcomes of disease related complications and treatment"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7971-051X","authenticated-orcid":false,"given":"Beman Roy","family":"Khulpateea","sequence":"first","affiliation":[]},{"given":"Annette","family":"Paulson","sequence":"additional","affiliation":[]},{"given":"Matthew","family":"Carlson","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8215-5887","authenticated-orcid":false,"given":"David Scott","family":"Miller","sequence":"additional","affiliation":[]},{"given":"Jayanthi","family":"Lea","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2019-000386_bb0010","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2019-000386_bb0015","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2019-000386_bb0020","first-page":"S43","article-title":"Carcinoma of the cervix uteri. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Quinn","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2019-000386_bb0025","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ygyno.2011.02.024","article-title":"Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group Study","volume":"121","author":"Rose","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000386_bb0030","first-page":"4989","article-title":"Radiation therapy for stage IVA cervical cancer","volume":"33","author":"Murakami","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1136\/ijgc-2019-000386_bb0035","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ygyno.2007.04.030","article-title":"Vesicovaginal fistula formation in patients with stage IVA cervical carcinoma","volume":"106","author":"Moore","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000386_bb0040","doi-asserted-by":"crossref","first-page":"112855","DOI":"10.18632\/oncotarget.22836","article-title":"Radiation therapy for stage IVA uterine cervical cancer: treatment outcomes including prognostic factors and risk of vesicovaginal and rectovaginal fistulas","volume":"8","author":"Hata","year":"2017","journal-title":"Oncotarget"},{"key":"10.1136\/ijgc-2019-000386_bb0045","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2268-3","article-title":"The prognostic value of rectal invasion for stage IVA uterine cervical cancer treated with radiation therapy","volume":"16","author":"Wakatsuki","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1136\/ijgc-2019-000386_bb0050","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ygyno.2012.07.103","article-title":"Neighborhood deprivation and risk of cervical cancer morbidity and mortality: a multilevel analysis from Sweden","volume":"127","author":"Li","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000386_bb0055","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/sj.bjc.6605949","article-title":"A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status","volume":"103","author":"Louwman","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2019-000386_bb0060","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.currproblcancer.2007.01.001","article-title":"Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States","volume":"31","author":"Akers","year":"2007","journal-title":"Curr Probl Cancer"},{"key":"10.1136\/ijgc-2019-000386_bb0065","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1525-1497.2003.20807.x","article-title":"Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care","volume":"18","author":"Goel","year":"2003","journal-title":"J Gen Intern Med"},{"key":"10.1136\/ijgc-2019-000386_bb0070","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0361-090X(03)00062-X","article-title":"Cervical cancer mortality among foreign-born women living in the United States, 1985 to 1996","volume":"27","author":"Seeff","year":"2003","journal-title":"Cancer Detect Prev"},{"key":"10.1136\/ijgc-2019-000386_bb0075","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ygyno.2006.03.054","article-title":"Advanced cervical cancer treatment in Harris County: pilot evaluation of factors that prevent optimal therapy","volume":"103","author":"Ramondetta","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000386_bb0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijgo.2009.02.009","article-title":"Revised FIGO staging for carcinoma of the cervix","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2019-000386_bb0085","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1200\/JCO.2009.25.4151","article-title":"Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis","volume":"28","author":"Kidd","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-000386_bb0090","first-page":"1024","author":"American Joint Committee on Cancer, American Cancer Society","year":"2017"},{"key":"10.1136\/ijgc-2019-000386_bb0095","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/0360-3016(94)00635-X","article-title":"The adverse effect of treatment prolongation in cervical carcinoma","volume":"32","author":"Petereit","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2019-000386_bb0100","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0360-3016(93)90522-W","article-title":"Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome","volume":"27","author":"Girinsky","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2019-000386_bb0105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brachy.2011.07.003","article-title":"American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles","volume":"11","author":"Viswanathan","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1136\/ijgc-2019-000386_bb0110","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1200\/JCO.1999.17.7.2055","article-title":"Chemoradiation and adjuvant chemotherapy in cervical cancer","volume":"17","author":"Wong","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-000386_bb0115","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/IGC.0b013e3181d224c8","article-title":"Can we predict vesicovaginal or rectovaginal fistula formation in patients with stage IVA cervical cancer?","volume":"20","author":"Biewenga","year":"2010","journal-title":"Int J Gynecol Cancer"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24023004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24023004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2019-000386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:26:07Z","timestamp":1753233967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24023004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1048891X24023004"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2019-000386","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stage IVA cervical cancer: outcomes of disease related complications and treatment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2019-000386","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}